What about the M4PM community?
The "Tumours, Organoids and Spheroids in Space - Microgravity for Personalised Medicine (M4PM)" Community is comprised of member companies and academics that currently grow and utilise, or contribute to tumours, organoids, spheroids in pursuit of (personalised) medicine (terrestrially).
Rationale
The M4PM community was initiated to bring together thought leaders in industry and academia to solve problems and advance personalised medicine through research in microgravity.
This innovation in drug discovery and personalised medicine in space will be done for the benefit of life on Earth. The M4PM Community will in parallel engage in activities that foster and enable the continued development of its members' R&D efforts that directly benefit their respective company business unit goals.
Purpose and scope
Feature key thought leaders
Contributing to the central topic of Microgravity for Personalised Medicine by bringing tumours, organoids and spheroids to space.
Develop and promote
Broad programs around 3D cell cultures, tumours, organoids, spheroids for drug testing and discovery, and for the development of personalised medicine.
Common goals & interests
Conducting work in research and very early stage pre-clinical arena where large companies will not be in competition. Community members will focus on common interests that benefit the group as well as their distinct corporate goals.
Create programs
Focusing on common goals of all community members while still enabling individual members to "pull through" relevant discoveries to support respective business unit goals where applicable.
Tackle challenges & Advance research
The Community members will identify key areas related to personalised medicine with an initial focus on using tumours, organoids, spheroids that could benefit from research and development demonstrations in Low Earth Orbit (LEO). Members will agree upon the theme and scope for open innovation competition(s) and programs that utilize LEO platforms to solve these issues. Community members that agree to participate in, and benefit from, a personalised medicine challenge will have the opportunity to fund a program.
Members
- Small, Medium and Large commercial companies
- Academics, University Labs, Research Institutes
- NGOs, Foundations, Non-Profits
- Industry Associations
- Clusters (Health & Biotech)
- Contract Research Organisations (CROs)
- Technological / Biological suppliers
- VCs, Private Equity / Capital
- Other thought leaders
